{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:29:51Z","timestamp":1790616591122,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejim.2024.08.012","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T03:18:08Z","timestamp":1724037488000},"page":"162-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Empagliflozin controls cirrhotic refractory ascites along with improvement of natriuresis and circulatory, cardiac, and renal function: A pilot study"],"prefix":"10.1016","volume":"130","author":[{"given":"Georgios","family":"Kalambokis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Tsiakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7173-5352","authenticated-orcid":false,"given":"Sebastien","family":"Filippas-Ntekouan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Christaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3958-2266","authenticated-orcid":false,"given":"Haralampos","family":"Milionis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2024.08.012_bib0001","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the study of liver diseases","volume":"74","author":"Scott","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2024.08.012_bib0002","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3748\/wjg.v20.i10.2555","article-title":"Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis","volume":"20","author":"Bolognesi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2024.08.012_bib0003","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jceh.2021.04.012","article-title":"Hepatogenous Diabetes: a Primer","volume":"11","author":"Nath","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.ejim.2024.08.012_bib0004","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/ejhf.2967","article-title":"Sodium-glucose cotransporter-2 inhibitors in heart failure: potential decongestive mechanisms and current clinical studies","volume":"25","author":"Biegus","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2024.08.012_bib0005","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.cgh.2020.05.021","article-title":"SGLT2 inhibitors in liver patients","volume":"18","author":"Hsiang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2024.08.012_bib0006","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.31270","article-title":"Sodium-glucose cotransporter 2 inhibitors ameliorate ascites and peripheral edema in patients with cirrhosis and diabetes","volume":"72","author":"Montalvo-Gordon","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2024.08.012_bib0007","doi-asserted-by":"crossref","first-page":"618","DOI":"10.14309\/ajg.0000000000000995","article-title":"Empagliflozin eliminates refractory ascites and hepatic hydrothorax in a patient with primary biliary cirrhosis","volume":"116","author":"Kalambokis","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2024.08.012_bib0008","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/ckj\/sfab266","article-title":"Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor","volume":"15","author":"Miyamoto","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ejim.2024.08.012_bib0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of cardiovascular imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ejim.2024.08.012_bib0010","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/0016-5085(95)90759-9","article-title":"Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis","volume":"109","author":"M\u00f8ller","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2024.08.012_bib0011","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00392-023-02164-w","article-title":"Effects of empagliflozin on left ventricular diastolic function in addition to usual care in individuals with type 2 diabetes mellitus-results from the randomized, double-blind, placebo-controlled EmDia trial","volume":"112","author":"Prochaska","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ejim.2024.08.012_bib0012","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/MEG.0000000000002762","article-title":"Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites","volume":"36","author":"Kalambokis","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524003509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524003509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T13:09:43Z","timestamp":1733144983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524003509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":12,"alternative-id":["S0953620524003509"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.08.012","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin controls cirrhotic refractory ascites along with improvement of natriuresis and circulatory, cardiac, and renal function: A pilot study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}